CASE DISCUSSION
2D Echo in Sepsis
Presented from India by Dr. Manimala RaoViews
6,257
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
2D Echo is an invaluable tool in assessing cardiac function during sepsis, aiding in early diagnosis and management. It helps identify sepsis-induced myocardial dysfunction, characterized by reduced left ventricular contractility and diastolic dysfunction. 2D Echo allows for the evaluation of...
Case Summary
- Echocardiography allows visualization of heart valves, wall structure, fluid presence, and air cavities, assisting in cardiac surgery assessments. Transesophageal echocardiography (TEE) is now commonly used, offering a comprehensive view. It also aids in identifying aortic dissections in patients presenting with severe chest pain, looking for tell-tale signs like a double shadow.
Speaker Profile
Dr. Manimala Rao
Alumni- All India Institute of Medical SciencesHead Anesthesiology & Critical Care, Director Critical Care, Yashoda Hospitals, Hyderabad
Dr. S. Manimala Rao is a pioneering figure in anaesthesiology and critical care medicine in India. She completed her MBBS from Osmania Medical College and her MD from AIIMS, New Delhi (1972). She has an extensive academic background, having served as Assistant Professor at Gandhi Medical College and as Associate Professor, Professor, HOD, and Dean at NIMS (Nizams Institute of Medical Sciences), Hyderabad. She has been the President of RSACP, State Chapter ISA, Vice President of ISA & Critical Care, and Chairperson of the MOHAN Foundation. She has published over 100 papers in national and international journals and holds additional qualification DA (London). Currently, she serves as Head of Anaesthesiology & Critical Care and Director of Critical Care at Yashoda Hospitals, Hyderabad. She is widely regarded as one of the most senior and respected intensivists in South India.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.